We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) ...
However, as groundbreaking as these therapies are, they also pose unique challenges for the drug development process, particularly regarding quality assurance (QA). The role of QA is more critical ...
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...
For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...
Our certificate program will strengthen your counseling skills and prepare you for licensure in Minnesota as an alcohol and drug counselor ... Engagement in development of “self of the therapist” ...
The human body is teeming with trillions of symbiotic microorganisms, profoundly impacting our well-being. Within the gut, ...
Parasitic diseases such as malaria, schistosomiasis, and toxoplasmosis are major global health concerns, exacerbated by the rising prevalence of ...
Given Yakult’s record in attaining 2%-4% penetration in many emerging markets, upside potential in the areas outside three first-tier cities—currently representing 80% of Yakult’s target population in ...
The preparation of the Common Technical Document (CTD), a mandatory component involving extensive data compilation for regulatory submissions, exemplifies a process that could benefit from AI ...
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
Accurate monitoring of particle size and growth is essential to ensure scalability in the development of transfection vectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results